AR
argenx SE
ARGNF · OTC
$995.00 -1.51% (-$15.26)
1M -0.56%
Market Cap $62.8B
P/E Ratio 46.72x
Div. Yield -
ROE 19.68%
Bulios Fair Price
$803.32
19.3% downside
Trenutna cena
$995
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ARGNF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
10 /100
Expensive P/E 46.72x
P/FCF 71.72x
EV/EBITDA 58.89x
Growth
100 /100
Growing Rev. growth 113.97%
Book val. growth 37.56%
EPS growth N/A
Profitability
98 /100
Strong Gross margin 89.14%
FCF margin 20.28%
Net margin 31.12%
Quality
78 /100
Excellent ROIC 13.83%
Asset turnover 0.50x
ROE 19.68%
Debt
100 /100
Low Debt/Equity 0.01x
Net debt/EBITDA -3.38x
Current ratio 5.23x
Stability
18 /100
Unstable Beta -0.02x
Profitable years 2
Rev. volatility 52.33%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARGNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Karen Massey
Employees
1,863
Headquarters
Amsterdam
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report
04 MAR.
Earnings
Upcoming earnings report